EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a biopharmaceutical Company focusing on commercializing its prescription Avenova® Lid and Lash Cleanser for the domestic eye care market, reports financial results for the three and 12 months ended December 31, 2015, and provides a business update. Fourth Quarter 2015 versus Third Quarter 2015 Avenova Highlights 41% increase in sales to a record $1.6 million 29% increase in the number of optometrists and ophtha
SYLMAR, Calif.–(BUSINESS WIRE)–Second Sight Medical Products, Inc. (NASDAQ: EYES) (“Second Sight” or “the Company”), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, today repor…
The ForeseeHome AMD monitoring program is available by prescription for eligible Medicare patients in the U.S. who have dry age-related macular degeneration and are at risk for developing wet AMD, Notal Vision announced in a press release. “Notal Vision is extremely pleased to achieve this significant milestone with the ForeseeHome AMD monitoring system. We have worked diligently for almost 2 years with the goal of ensuring this device is available to eligible patients enrolled in Medicare,” Barak Azmon, MD, CEO of Notal Vision, said in the release.
ATHENS, Greece — At the European Society of Cataract and Refractive Surgeons winter meeting, George D. Kymionis, MD, PhD, discusses positive long-term results of combined corneal cross-linking and topography-guided PRK in patients with corneal disease.
ATHENS, Greece — At the European Society of Cataract and Refractive Surgeons winter meeting, George D. Kymionis, MD, PhD, discusses positive long-term results of combined corneal cross-linking and topography-guided PRK in patients with corneal disease.
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/798z9j/rhinoconjunctivit) has announced the addition of the “Rhino-Conjunctivitis Global Clinical Trials Review, H2, 2015” report to their offering. The clinical …